How healthy are these companies today?

Revenue +38.6% YoY (qtr ending 2026-09-30); TTM op margin 40.2% (+2.3pp); margin beats 90% of 10 peers; TTM net income $27.6B.

6mo +40.5% vs SPY -0.0%, XLV +30.3%; -4.5% from 52w high; +23.3% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

90 relevant headlines in 30d (9 duplicates, 1 off-topic dropped): 66 positive, 11 negative. Tone +0.33 (AI (claude)).

Release 2026-10-29, guidance raised: Lilly delivered a very strong, volume-driven quarter and raised revenue and margin guidance meaningfully, with the headline EPS guidance cut entirely due to acquired IPR&D charges, t…

Short interest -32.3% over 3mo; 3.0 days to cover; short volume 40% of trades (20d) vs 42% (6mo).

1x Director/officer departure or appointment; 2 new activist (13D) stake(s) (12 months).

Quarter to 2026-06-30: holders +6.9% (4,620), shares held +4.0%; typical stock +4.7% / +8.3%.

Revenue +18.8% YoY (qtr ending 2026-09-30); TTM op margin 47.1% (+0.8pp); margin beats 100% of 12 peers; TTM net income $142.6B.

6mo +29.1% vs SPY -0.0%, XLK -7.2%; -4.5% from 52w high; +20.9% vs 200-day avg.

0 insider(s) bought $0 on open market; 3 sold $17.8M outside 10b5-1 plans. 1 routine trader(s) discounted.

88 relevant headlines in 30d (7 duplicates, 5 off-topic dropped): 59 positive, 20 negative. Tone +0.27 (AI (claude)).

Release 2026-10-28, guidance none: Microsoft had a strong quarter, with accelerating cloud and Azure growth, rising margins and a record backlog, offset by a doubling of capex that cut free cash flow and by no written g…

Short interest -28.9% over 3mo; 3.2 days to cover; short volume 38% of trades (20d) vs 38% (6mo).

4x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +1.5% (6,214), shares held +10.6%; typical stock +4.7% / +8.3%.

Revenue +43.3% YoY (qtr ending 2026-09-30); TTM op margin 11.5% (+9.9pp); margin beats 70% of 10 peers; TTM net income $12.9B.

6mo +40.8% vs SPY -0.0%, XLE +9.2%; -24.6% from 52w high; +19.8% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $5.7M outside 10b5-1 plans. 1 seller(s) cut stake 25%+.

57 relevant headlines in 30d (3 duplicates, 4 off-topic dropped): 45 positive, 9 negative. Tone +0.26 (AI (claude)).

Release 2026-10-22, guidance none: Valero posted exceptionally strong Q3 2026 earnings, with adjusted EPS of $23.90 against $3.66 a year earlier, on a refining margin spike, a renewable diesel recovery and a very strong…

Short interest -27.0% over 3mo; 3.3 days to cover; short volume 49% of trades (20d) vs 52% (6mo).

2x Director/officer departure or appointment (12 months).

Revenue +13.2% YoY (qtr ending 2026-09-30); TTM op margin 61.2% (+1.3pp); margin beats 100% of 10 peers; TTM net income $23.5B.

6mo +31.0% vs SPY -0.0%, XLI -6.6%; -3.2% from 52w high; +22.9% vs 200-day avg.

0 insider(s) bought $0 on open market; 4 sold $60.6M outside 10b5-1 plans. 2 seller(s) cut stake 25%+.

97 relevant headlines in 30d (3 duplicates, 0 off-topic dropped): 64 positive, 16 negative. Tone +0.24 (AI (claude)).

Release 2026-10-27, guidance none: Visa posted strong, broad-based growth and double-digit EPS gains with heavy capital returns, but expenses and client incentives outpaced revenue and the release gave no outlook.

Short interest -13.0% over 3mo; 3.6 days to cover; short volume 44% of trades (20d) vs 42% (6mo).

No red-flag 8-K items in 12 months.

Quarter to 2026-06-30: holders +3.5% (4,564), shares held +16.5%; typical stock +4.7% / +8.3%.

Revenue +15.3% YoY (qtr ending 2026-09-30); TTM op margin 40.1% (-0.5pp); TTM net income $7.6B.

6mo +11.3% vs SPY -0.0%, XLI -6.6%; -6.2% from 52w high; +7.2% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $789.5K outside 10b5-1 plans.

58 relevant headlines in 30d (3 duplicates, 1 off-topic dropped): 41 positive, 12 negative. Tone +0.21 (AI (claude)).

Release 2026-10-22, guidance maintained: Record quarter with strong volume, pricing and EPS growth and better cash flow and leverage, but fuel pressure on margins and unchanged guidance (high-single-digit EPS growth aff…

Short interest -1.1% over 3mo; 12.9 days to cover; short volume 56% of trades (20d) vs 53% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +5.1% (2,883), shares held +8.2%; typical stock +4.7% / +8.3%.

Revenue +11.7% YoY (qtr ending 2026-09-26); TTM op margin 33.0% (+1.0pp); margin beats 64% of 14 peers; TTM net income $132.2B.

6mo +17.1% vs SPY -0.0%, XLK -7.2%; -2.0% from 52w high; +14.7% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $15.6M outside 10b5-1 plans.

92 relevant headlines in 30d (5 duplicates, 3 off-topic dropped): 39 positive, 38 negative. Tone +0.03 (AI (claude)).

Release 2026-11-02, guidance none: Strong, broad-based quarter and record year, with iPhone, Services, Mac and cash flow all up, but the release gives no guidance, margin was helped by one-off tariff refunds, and R&D an…

Short interest -10.2% over 3mo; 3.7 days to cover; short volume 53% of trades (20d) vs 48% (6mo).

4x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +1.7% (6,108), shares held +7.0%; typical stock +4.7% / +8.3%.

Revenue +12.1% YoY (qtr ending 2026-09-30); TTM op margin 13.1% (+2.1pp); margin beats 88% of 8 peers; TTM net income $134.8B.

6mo -3.6% vs SPY -0.0%, XLY -1.1%; -8.7% from 52w high; +6.3% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

84 relevant headlines in 30d (11 duplicates, 5 off-topic dropped): 65 positive, 13 negative. Tone +0.34 (AI (claude)).

Release 2026-10-29, guidance raised: Record margins, accelerating AWS growth and a strong Q4 outlook point to a strong operating quarter, but heavy AI capex is driving negative free cash flow and rapidly rising debt.

Short interest -12.1% over 3mo; 2.8 days to cover; short volume 34% of trades (20d) vs 31% (6mo).

1x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +3.4% (6,125), shares held +8.4%; typical stock +4.7% / +8.3%.

Revenue -0.4% YoY (qtr ending 2026-09-27); TTM op margin 6.7% (-7.9pp); margin beats 60% of 10 peers; TTM net income $4.0B.

6mo +17.6% vs SPY -0.0%, XLV +30.3%; -3.2% from 52w high; +12.7% vs 200-day avg.

3 insider(s) bought $3.0M on open market; 1 sold $134.7K outside 10b5-1 plans.

89 relevant headlines in 30d (3 duplicates, 2 off-topic dropped): 70 positive, 5 negative. Tone +0.35 (AI (claude)).

Release 2026-11-03, guidance raised: Pfizer raised full-year revenue and EPS guidance on strong growth in its launched and acquired products and margin improvement, but flat Q3 revenue and EPS, steep COVID and Prevnar d…

Short interest -15.9% over 3mo; 4.5 days to cover; short volume 43% of trades (20d) vs 42% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders -2.8% (2,828), shares held +9.9%; typical stock +4.7% / +8.3%.

Revenue +42.0% YoY (qtr ending 2026-09-30); TTM op margin 27.5% (-10.5pp); margin beats 78% of 18 peers; TTM net income $4.5B.

6mo +15.7% vs SPY -0.0%, XLU -3.1%; -15.9% from 52w high; +7.7% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

53 relevant headlines in 30d (3 duplicates, 4 off-topic dropped): 29 positive, 13 negative. Tone +0.15 (AI (claude)).

Release 2026-10-29, guidance raised: Cheniere had a strong quarter with double-digit growth in volumes and EBITDA, sharply higher full-year guidance, and a larger dividend, and the only real drag is non-cash derivative…

Short interest +10.1% over 3mo; 3.1 days to cover; short volume 44% of trades (20d) vs 42% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders -1.0% (1,341), shares held +5.0%; typical stock +4.7% / +8.3%.

Revenue +32.7% YoY (qtr ending 2026-09-30); margin beats 67% of 9 peers.

6mo +12.3% vs SPY -0.0%, XLE +9.2%; -11.4% from 52w high; +7.4% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

71 relevant headlines in 30d (1 duplicates, 3 off-topic dropped): 46 positive, 13 negative. Tone +0.21 (AI (claude)).

Release 2026-10-30, guidance none: Strong quarter with sharply higher YTD earnings and free cash flow, a deleveraging balance sheet and continued shareholder returns (including a $20B 2027 buyback plan), but there is no…

Short interest -0.9% over 3mo; 3.9 days to cover; short volume 50% of trades (20d) vs 46% (6mo).

No red-flag 8-K items in 12 months.

STALE: latest data is 221 days old, score halved. Revenue +9.5% YoY (qtr ending 2026-03-31); TTM op margin 27.7% (+0.7pp); margin beats 94% of 18 peers; TTM net income $5.1B.

6mo +4.1% vs SPY -0.0%, XLU -3.1%; -2.6% from 52w high; +3.6% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $438.0K outside 10b5-1 plans.

51 relevant headlines in 30d (7 duplicates, 1 off-topic dropped): 27 positive, 12 negative. Tone +0.16 (AI (claude)).

Release 2026-11-05, guidance maintained: Duke posted solid double-digit adjusted EPS growth and narrowed 2026 guidance toward the top end, but cash flow weakened and debt and financing costs are rising to fund a heavy c…

Short interest +2.4% over 3mo; 4.5 days to cover; short volume 55% of trades (20d) vs 53% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +1.6% (2,479), shares held +24.5%; typical stock +4.7% / +8.3%.

Revenue +3.0% YoY (qtr ending 2026-09-30); TTM op margin 16.0% (+0.2pp); margin beats 45% of 20 peers; TTM net income $11.6B.

6mo +15.8% vs SPY -0.0%, XLF +12.5%; -3.0% from 52w high; +8.6% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $1.5M outside 10b5-1 plans.

53 relevant headlines in 30d (2 duplicates, 1 off-topic dropped): 18 positive, 14 negative. Tone +0.01 (AI (claude)).

Release 2026-10-14, guidance none: Underwriting profitability and policy growth are strong, but premium growth is slowing, rate-driven investment marks hurt September, and the release gives no forward guidance.

Short interest -26.4% over 3mo; 2.3 days to cover; short volume 50% of trades (20d) vs 44% (6mo).

3x Director/officer departure or appointment (12 months).

Revenue +8.1% YoY (qtr ending 2026-09-30); TTM op margin 42.0% (+1.4pp); margin beats 50% of 6 peers; TTM net income $65.9B.

6mo +12.6% vs SPY -0.0%, XLF +12.5%; -7.9% from 52w high; +4.1% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

63 relevant headlines in 30d (5 duplicates, 32 off-topic dropped): 32 positive, 26 negative. Tone -0.03 (AI (claude)).

Release 2026-10-13, guidance none: Solid underlying 3Q26 with double-digit growth in net interest income, loans and revenue and lower provisions, partly offset by 12% expense growth and falling capital ratios. The relea…

Short interest -13.2% over 3mo; 3.3 days to cover; short volume 42% of trades (20d) vs 44% (6mo).

3x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +2.3% (5,126), shares held +2.4%; typical stock +4.7% / +8.3%.

Revenue +105.9% YoY (qtr ending 2026-07-26); TTM op margin 65.2% (+7.1pp); margin beats 97% of 30 peers; TTM net income $192.9B.

6mo -14.8% vs SPY -0.0%, XLK -7.2%; -22.0% from 52w high; -8.7% vs 200-day avg.

0 insider(s) bought $0 on open market; 2 sold $1.2B outside 10b5-1 plans. 1 seller(s) cut stake 25%+. 1 routine trader(s) discounted.

83 relevant headlines in 30d (13 duplicates, 4 off-topic dropped): 39 positive, 35 negative. Tone -0.02 (AI (claude)).

Release 2026-08-26, guidance raised: Very strong growth and margins, and the Q3 revenue guide of $108B is well above Q2's $96B, but cash conversion weakened in the quarter and gross margin is guided down slightly. The r…

Short interest -6.9% over 3mo; 2.9 days to cover; short volume 34% of trades (20d) vs 38% (6mo).

5x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +3.2% (5,959), shares held +7.9%; typical stock +4.7% / +8.3%.

Revenue +85.5% YoY (qtr ending 2026-08-02); TTM op margin 48.0% (+10.3pp); margin beats 93% of 30 peers; TTM net income $38.3B.

6mo -31.2% vs SPY -0.0%, XLK -7.2%; -38.8% from 52w high; -19.8% vs 200-day avg.

1 insider(s) bought $373.6K on open market; 3 sold $33.7M outside 10b5-1 plans. 1 seller(s) cut stake 25%+. 1 routine trader(s) discounted.

77 relevant headlines in 30d (15 duplicates, 8 off-topic dropped): 43 positive, 27 negative. Tone +0.10 (AI (claude)).

Release 2026-09-02, guidance raised: Broadcom reported a very strong quarter, with AI-driven revenue up 86%, record profit and cash flow, and Q4 guidance implying a further sharp acceleration, though working capital and…

Short interest -21.9% over 3mo; 2.4 days to cover; short volume 26% of trades (20d) vs 36% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +4.5% (4,821), shares held +7.3%; typical stock +4.7% / +8.3%.

Revenue +3.3% YoY (qtr ending 2026-09-30); TTM op margin 11.7% (+5.9pp); margin beats 71% of 21 peers; TTM net income $2.5B.

6mo -11.2% vs SPY -0.0%, XLP +9.5%; -20.6% from 52w high; -8.0% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

61 relevant headlines in 30d (2 duplicates, 0 off-topic dropped): 31 positive, 16 negative. Tone +0.17 (AI (claude)).

Release 2026-11-03, guidance raised: ADM posted a strong Q3 with adjusted EPS up 92%, broad segment growth and a raised full-year guide, though policy-dependent biofuels earnings and weaker operating cash flow temper th…

Short interest -27.4% over 3mo; 4.0 days to cover; short volume 53% of trades (20d) vs 56% (6mo).

4x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +5.6% (1,161), shares held +20.9%; typical stock +4.7% / +8.3%.

Revenue +5.7% YoY (qtr ending 2026-08-02); TTM op margin 12.4% (-0.7pp); margin beats 67% of 6 peers; TTM net income $14.2B.

6mo +11.9% vs SPY -0.0%, XLY -1.1%; -10.3% from 52w high; +4.1% vs 200-day avg.

0 insider(s) bought $0 on open market; 4 sold $3.3M outside 10b5-1 plans. 1 routine trader(s) discounted.

81 relevant headlines in 30d (7 duplicates, 2 off-topic dropped): 48 positive, 20 negative. Tone +0.11 (AI (claude)).

Release 2026-08-18, guidance maintained: Home Depot posted a modest beat with 5.7% sales growth and 5% adjusted EPS growth, but demand is soft, margins are slightly lower, and it only reaffirmed a low-growth fiscal 2026…

Short interest -4.7% over 3mo; 2.2 days to cover; short volume 40% of trades (20d) vs 39% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +0.2% (4,094), shares held +8.2%; typical stock +4.7% / +8.3%.

Revenue +4.0% YoY (qtr ending 2026-09-30); TTM op margin 22.6% (-1.6pp); margin beats 82% of 66 peers; TTM net income $16.0B.

6mo +17.0% vs SPY -0.0%, XLP +9.5%; -1.1% from 52w high; +12.2% vs 200-day avg.

0 insider(s) bought $0 on open market; 12 sold $32.0M outside 10b5-1 plans. 7 seller(s) cut stake 25%+. 6 routine trader(s) discounted.

67 relevant headlines in 30d (2 duplicates, 1 off-topic dropped): 45 positive, 14 negative. Tone +0.19 (AI (claude)).

Release 2026-10-22, guidance maintained: P&G posted solid 4% organic sales growth and strong cash conversion, but margin compression held EPS growth to about 1%, and management kept its organic sales and EPS guidance, r…

Short interest -4.5% over 3mo; 2.4 days to cover; short volume 36% of trades (20d) vs 36% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +1.6% (4,015), shares held +40.2%; typical stock +4.7% / +8.3%.

Revenue +9.2% YoY (qtr ending 2026-09-30); TTM op margin 25.3% (-2.1pp); margin beats 79% of 66 peers; TTM net income $7.0B.

6mo +2.8% vs SPY -0.0%, XLB +0.2%; -5.4% from 52w high; +4.6% vs 200-day avg.

1 insider(s) bought $47.9K on open market; 3 sold $52.8M outside 10b5-1 plans. 2 seller(s) cut stake 25%+.

69 relevant headlines in 30d (7 duplicates, 0 off-topic dropped): 55 positive, 8 negative. Tone +0.21 (AI (claude)).

Release 2026-10-29, guidance maintained: Linde delivered steady mid-single-digit underlying growth, record adjusted EPS and solid cash flow, and its full-year adjusted EPS guidance of $17.82-$17.92 (8-9% growth) was giv…

Short interest -5.2% over 3mo; 2.9 days to cover; short volume 52% of trades (20d) vs 47% (6mo).

No red-flag 8-K items in 12 months.

Quarter to 2026-06-30: holders +3.7% (2,315), shares held +6.3%; typical stock +4.7% / +8.3%.

Revenue +1.5% YoY (qtr ending 2026-09-30); TTM op margin 20.9% (-2.2pp); margin beats 92% of 12 peers; TTM net income $16.9B.

6mo -0.1% vs SPY -0.0%, XLC -8.8%; -9.8% from 52w high; -0.0% vs 200-day avg.

0 insider(s) bought $0 on open market; 1 sold $3.5M outside 10b5-1 plans. 1 seller(s) cut stake 25%+.

64 relevant headlines in 30d (5 duplicates, 5 off-topic dropped): 25 positive, 21 negative. Tone -0.07 (AI (claude)).

Release 2026-10-26, guidance raised: Verizon posted a strong quarter, with record EBITDA and margins, a sharp rebound in subscriber additions, higher free cash flow, and a third consecutive guidance raise, though top-li…

Short interest -2.7% over 3mo; 2.8 days to cover; short volume 46% of trades (20d) vs 50% (6mo).

7x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders -2.7% (3,143), shares held +18.7%; typical stock +4.7% / +8.3%.

STALE: latest data is 221 days old, score halved. Revenue +1.7% YoY (qtr ending 2026-03-31); TTM op margin 31.8% (-0.3pp); margin beats 93% of 14 peers; TTM net income $8.2B.

6mo -7.0% vs SPY -0.0%, XLU -3.1%; -9.8% from 52w high; +0.5% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

49 relevant headlines in 30d (4 duplicates, 4 off-topic dropped): 33 positive, 6 negative. Tone +0.25 (AI (claude)).

Release 2026-10-21, guidance maintained: NextEra posted solid ~10% adjusted EPS growth with strong renewables backlog and FPL investment growth and reaffirmed its 2026 guidance, targeting the high end, but gave no raise…

Short interest +20.0% over 3mo; 5.1 days to cover; short volume 62% of trades (20d) vs 51% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +1.0% (3,038), shares held +24.0%; typical stock +4.7% / +8.3%.

Revenue +5.9% YoY (qtr ending 2026-07-31); TTM op margin 4.4% (+0.2pp); margin beats 27% of 11 peers; TTM net income $22.1B.

6mo -1.4% vs SPY -0.0%, XLP +9.5%; -6.2% from 52w high; +6.0% vs 200-day avg.

0 insider(s) bought $0 on open market; 2 sold $1.0B outside 10b5-1 plans.

78 relevant headlines in 30d (4 duplicates, 5 off-topic dropped): 45 positive, 20 negative. Tone +0.19 (AI (claude)).

Release 2026-08-20, guidance raised: Walmart posted a solid quarter with strong eCommerce and advertising growth and raised its full-year outlook, but much of the profit upside came from tariff refunds that will be rein…

Short interest +1.2% over 3mo; 3.6 days to cover; short volume 44% of trades (20d) vs 43% (6mo).

5x Director/officer departure or appointment; 1x Delisting / listing-rule notice (12 months).

Quarter to 2026-06-30: holders +0.2% (4,398), shares held +40.3%; typical stock +4.7% / +8.3%.

Revenue +20.9% YoY (qtr ending 2026-09-26); TTM op margin 2.9% (+7.4pp); margin beats 53% of 15 peers; TTM net income -$12.0B.

6mo -56.5% vs SPY -0.0%, XLK -7.2%; -60.1% from 52w high; -35.3% vs 200-day avg.

1 insider(s) bought $19.7M on open market; 1 sold $2.5M outside 10b5-1 plans.

79 relevant headlines in 30d (17 duplicates, 4 off-topic dropped): 22 positive, 48 negative. Tone -0.22 (AI (claude)).

Release 2026-10-29, guidance maintained: Q3 was a strong beat, driven by data center growth and margin expansion, but the Q4 guide steps down sharply in revenue and margin and management expects the PC slowdown to conti…

Short interest +22.8% over 3mo; 1.5 days to cover; short volume 37% of trades (20d) vs 42% (6mo).

3x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +39.7% (3,557), shares held +38.8%; typical stock +4.7% / +8.3%.

STALE: latest data is 221 days old, score halved. Revenue +7.4% YoY (qtr ending 2026-03-31); TTM op margin 52.4% (-2.1pp); margin beats 62% of 13 peers; TTM net income $3.7B.

6mo -10.5% vs SPY -0.0%, XLRE +0.4%; -14.7% from 52w high; -6.8% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

47 relevant headlines in 30d (4 duplicates, 1 off-topic dropped): 32 positive, 9 negative. Tone +0.17 (AI (claude)).

Release 2026-10-15, guidance raised: Prologis posted solid Q3 growth in Core FFO, EBITDA and rents with a strong balance sheet and tightened, higher full-year guidance, though development value creation and same-store N…

Short interest +29.7% over 3mo; 4.0 days to cover; short volume 45% of trades (20d) vs 47% (6mo).

5x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +5.1% (1,736), shares held +27.4%; typical stock +4.7% / +8.3%.

Revenue +24.7% YoY (qtr ending 2026-09-30); TTM op margin 33.3%; margin beats 90% of 10 peers; TTM net income $235.7B.

6mo -26.6% vs SPY -0.0%, XLK -7.2%; -29.2% from 52w high; -16.0% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

86 relevant headlines in 30d (12 duplicates, 2 off-topic dropped): 40 positive, 30 negative. Tone -0.02 (AI (claude)).

Release 2026-10-28, guidance none: Operating results were very strong, led by Cloud growth of 103% and Search acceleration, but the company is spending heavily and funding it with debt and equity, so free cash flow is n…

Short interest -0.3% over 3mo; 3.4 days to cover; short volume 38% of trades (20d) vs 40% (6mo).

5x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +3.9% (5,778), shares held +6.9%; typical stock +4.7% / +8.3%.

Revenue +3.9% YoY (qtr ending 2026-09-30); TTM op margin 10.3% (+20.5pp); margin beats 8% of 40 peers; TTM net income $7.7B.

6mo -27.2% vs SPY -0.0%, XLI -6.6%; -31.2% from 52w high; -19.4% vs 200-day avg.

3 insider(s) bought $1.8M on open market; 0 sold $0 outside 10b5-1 plans.

78 relevant headlines in 30d (4 duplicates, 1 off-topic dropped): 32 positive, 32 negative. Tone -0.04 (AI (claude)).

Release 2026-10-27, guidance none: Boeing's results improved sharply from last year's charge-hit quarter, with record backlog, positive free cash flow and key certifications, but it is still loss-making, the commercial…

Short interest -0.3% over 3mo; 1.9 days to cover; short volume 37% of trades (20d) vs 44% (6mo).

2x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +5.4% (2,624), shares held +3.6%; typical stock +4.7% / +8.3%.

Revenue +5.9% YoY (qtr ending 2026-09-27); TTM op margin 17.9% (-16.3pp); margin beats 10% of 10 peers; TTM net income $16.1B.

6mo +26.1% vs SPY -0.0%, XLV +30.3%; -0.8% from 52w high; +11.9% vs 200-day avg.

0 insider(s) bought $0 on open market; 6 sold $70.2M outside 10b5-1 plans. 4 seller(s) cut stake 25%+.

46 relevant headlines in 30d (3 duplicates, 8 off-topic dropped): 23 positive, 13 negative. Tone +0.16 (AI (claude)).

Release 2026-10-13, guidance none: Sales growth was solid, driven by oncology and Tremfya, but Q3 profit and margins fell on a large litigation charge, higher R&D and Stelara erosion. This release gave no guidance and n…

Short interest -38.9% over 3mo; 2.0 days to cover; short volume 33% of trades (20d) vs 47% (6mo).

1x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +2.2% (4,675), shares held +6.4%; typical stock +4.7% / +8.3%.

Revenue +17.3% YoY (qtr ending 2026-09-30); TTM op margin 18.3% (+0.7pp); margin beats 86% of 14 peers; TTM net income $11.8B.

6mo -39.5% vs SPY -0.0%, XLI -6.6%; -47.3% from 52w high; -30.6% vs 200-day avg.

1 insider(s) bought $620.4K on open market; 4 sold $58.5M outside 10b5-1 plans. 2 seller(s) cut stake 25%+.

74 relevant headlines in 30d (4 duplicates, 0 off-topic dropped): 31 positive, 34 negative. Tone -0.04 (AI (claude)).

Release 2026-10-29, guidance none: Caterpillar posted very strong third-quarter growth and margin expansion with a record backlog, but the release gives no formal guidance, and working-capital build and tariff costs are…

Short interest -6.2% over 3mo; 2.8 days to cover; short volume 40% of trades (20d) vs 49% (6mo).

3x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders +9.2% (4,046), shares held +2.8%; typical stock +4.7% / +8.3%.

Revenue +112.5% YoY (qtr ending 2026-06-30); TTM op margin -3.0% (-9.3pp); margin beats 30% of 20 peers; TTM net income -$1.9B.

6mo -59.5% vs SPY -0.0%, XLK -7.2%; -66.4% from 52w high; -48.5% vs 200-day avg.

0 insider(s) bought $0 on open market; 11 sold $848.8M outside 10b5-1 plans. 4 seller(s) cut stake 25%+.

89 relevant headlines in 30d (7 duplicates, 4 off-topic dropped): 23 positive, 60 negative. Tone -0.26 (AI (claude)).

Release 2026-08-11, guidance none: Revenue and backlog growth were very strong, but margins weakened, interest costs and leverage rose, and the release gave no numeric guidance (it was deferred to the call), so the pict…

Short interest +8.4% over 3mo; 1.7 days to cover; short volume 48% of trades (20d) vs 53% (6mo).

No red-flag 8-K items in 12 months.

Quarter to 2026-06-30: holders +25.6% (966), shares held +37.6%; typical stock +4.7% / +8.3%.

Revenue -4.3% YoY (qtr ending 2026-08-31); TTM op margin 8.5% (+1.0pp); margin beats 20% of 10 peers; TTM net income $3.1B.

6mo -7.2% vs SPY -0.0%, XLB +0.2%; -41.6% from 52w high; -13.8% vs 200-day avg.

No open-market buys or discretionary sales; only routine/planned activity.

74 relevant headlines in 30d (16 duplicates, 10 off-topic dropped): 26 positive, 36 negative. Tone -0.09 (AI (claude)).

Release 2026-10-01, guidance lowered: Q1 had better margins and cost control but falling revenue, and the full-year outlook for a high-single-digit revenue decline and low EPS points to continued deterioration despite t…

Short interest +62.2% over 3mo; 1.9 days to cover; short volume 47% of trades (20d) vs 44% (6mo).

2x Exit/restructuring costs; 6x Director/officer departure or appointment (12 months).

Quarter to 2026-06-30: holders -8.3% (1,736), shares held +13.2%; typical stock +4.7% / +8.3%.